The filing

Disclosure under regulation 30 (LODR)- Preferential Issue

Company

Asston Pharmaceuticals Ltd · BSE 544445

Filed

2 July 2026, 18:26 IST

BSE category

Company Update / Preferential Issue

Tag

Fundraising · selected

Source

Open the filing on BSE →

Why it led

• First Fundraising from this company — not seen in the 68 trading days on record
• Micro cap
• 2 filings today

Selected by the ranker from 38 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

307 of 83,122 filings in the published window carry Fundraising · 0.37%

Around it

Also filed by Asston Pharmaceuticals Ltd on 2 July 2026

• Meeting Updates Meeting Update
• Announcement Regarding Extraordinary General Meeting Of The Company. AGM / EGM
• Update On Board Meeting Scheduled To Be Held On 02Nd July, 2026. General
• Board Meeting Outcome for Outcome Of The Board Meeting Scheduled To Be Held On 02Nd July, 2026. Board Outcome

Most recent filings from Asston Pharmaceuticals Ltd

• Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 SAST 2 September 2026
• Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 SAST 1 September 2026
• Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 SAST 31 August 2026